Comments
Loading...

VanEck Pharmaceutical ETF

PPHNASDAQ
Logo brought to you by Benzinga Data
$89.75
0.270.30%
Pre-Market: 4:20 PM EDT
Sector
Healthcare
Region
US
AUM
674.00M
Fund Score

VanEck Pharmaceutical ETF (NASDAQ:PPH) Quotes, Forecast and News Summary

VanEck Pharmaceutical ETF (NASDAQ: PPH) stock price, news, charts, stock research, profile.

Open-
High-
52 Wk High$99.51
AUM674.00M
Dividend$1.54
Ex-Div DateJul 1, 2024
Volume-
Market Cap$197.81B
Mgmt Fee0.35%
P/E Ratio25.51
Prev. Close$89.48
Low-
52 Wk Low$75.50
Shares Out6.09M
Yield1.60%
Div. FreqQuarterly
Avg. Volume Daily126.04K
Beta0.65
Avg. Expense Ratio0.36%
P/B Ratio3.19

FAQ

Q

How do I buy VanEck Pharmaceutical ETF (PPH) stock?

A

You can purchase shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) through any online brokerage.

View our list of the best stock brokerages

Q

Who are VanEck Pharmaceutical ETF (PPH) competitors?

A

There are no as such competitors for VanEck Pharmaceutical ETF.

Q

What is the forecast, or price target, for VanEck Pharmaceutical ETF (PPH) stock?

A

There is no analysis for VanEck Pharmaceutical ETF to provide a consensus price target.

Q

What is the current price for VanEck Pharmaceutical ETF (PPH)?

A

The stock price for VanEck Pharmaceutical ETF (NASDAQ: PPH) is $89.48 last updated November 13, 2024 at 4:15 PM EST.

Q

Does VanEck Pharmaceutical ETF (PPH) pay a dividend?

A

A quarterly cash dividend of 0.41 per share of Class A Common Stock. The quarterly cash dividend was payable on October 4, 2024 to stockholders of record on October 1, 2024.

Q

When is VanEck Pharmaceutical ETF (NASDAQ:PPH) reporting earnings?

A

VanEck Pharmaceutical ETF does not have any upcoming earnings scheduled.

Q

Is VanEck Pharmaceutical ETF (PPH) going to split?

A

There is no upcoming split for VanEck Pharmaceutical ETF.

Open-
High-
52 Wk High$99.51
AUM674.00M
Dividend$1.54
Ex-Div DateJul 1, 2024
Volume-
Market Cap$197.81B
Mgmt Fee0.35%
P/E Ratio25.51
Prev. Close$89.48
Low-
52 Wk Low$75.50
Shares Out6.09M
Yield1.60%
Div. FreqQuarterly
Avg. Volume Daily126.04K
Beta0.65
Avg. Expense Ratio0.36%
P/B Ratio3.19
ETF Details
SectorHealthcare
CategoryMid Performer-Mid Growth
Investment StyleLarge Cap Value
Fund InceptionDec 20, 2011
Managers
Griffin Driscoll
Peter H. Liao
DefinitionMost of the stocks in this Equity Fund have average financial performance and average growth potential
Investment Policy
The Fund normally invests at least 80 percent of its total assets in securities that comprise the Funds benchmark index. The Pharmaceutical Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. To be initially eligible for the Pharmaceutical Index, companies must generate at least 50 percent of their revenues from pharmaceuticals. Pharmaceuticals include companies engaged primarily in research (including research contractors) and development as well as production, marketing and sales of pharmaceuticals (excluding pharmacies). Of the largest 50 stocks in the pharmaceutical industry by full market capitalization, the top 25 by free-float market capitalization (i.e., includes only shares that are readily available for trading in the market) and three month average daily trading volume are included in the Pharmaceutical Index.
Top ETF Holdings
SymbolNameShare %
LLYEli Lilly & Co.11.7%
CONovo Nordisk A/S ADR9.41%
JNJJohnson & Johnson6.66%
MRKMerck & Company Inc.6.22%
ABBVAbbvie Inc Accenture P...6.06%
LNAstrazeneca Plc, ADR5.13%
GVMXXState Street Navigator...4.71%
SMNovartis Ag Sponsored ...4.70%
CORCencora Inc4.60%
MCKMckesson Corp.4.54%